# Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)

> **NCT07123779** · PHASE1 · NOT_YET_RECRUITING · sponsor: **35Pharma Inc** · enrollment: 40 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Heart Failure With Preserved Ejection Fraction

## Interventions

- **BIOLOGICAL:** HS235
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07123779
- **Lead sponsor:** 35Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2027-09
- **Final completion:** 2028-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07123779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07123779, "Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07123779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*